Page last updated: 2024-10-24

chlorambucil and Fibrosis, Inflammatory Perianeurysmal

chlorambucil has been researched along with Fibrosis, Inflammatory Perianeurysmal in 2 studies

Chlorambucil: A nitrogen mustard alkylating agent used as antineoplastic for chronic lymphocytic leukemia, Hodgkin's disease, and others. Although it is less toxic than most other nitrogen mustards, it has been listed as a known carcinogen in the Fourth Annual Report on Carcinogens (NTP 85-002, 1985). (Merck Index, 11th ed)
chlorambucil : A monocarboxylic acid that is butanoic acid substituted at position 4 by a 4-[bis(2-chloroethyl)amino]phenyl group. A chemotherapy drug that can be used in combination with the antibody obinutuzumab for the treatment of chronic lymphocytic leukemia.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hollingworth, P1
Denman, AM1
Gumpel, JM1
Moroni, G1
Faricciotti, A1
Farricciotti, A1
Cappelletti, M1
Ponticelli, C1

Other Studies

2 other studies available for chlorambucil and Fibrosis, Inflammatory Perianeurysmal

ArticleYear
Retroperitoneal fibrosis and polyarteritis nodosa successfully treated by intensive immunosuppression.
    Journal of the Royal Society of Medicine, 1980, Volume: 73, Issue:1

    Topics: Chlorambucil; Drug Therapy, Combination; Humans; Immunosuppression Therapy; Male; Middle Aged; Polya

1980
Retroperitoneal fibrosis and membranous nephropathy. Improvement of both diseases after treatment with steroids and immunosuppressive agents.
    Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 1999, Volume: 14, Issue:5

    Topics: Anti-Inflammatory Agents; Chlorambucil; Drug Therapy, Combination; Glomerulonephritis, Membranous; H

1999